Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-04-09FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Pantoprazole Sodium from Torrent Pharmaceuticals Limited under the ANDA program. This action upd…
-
FDA approval · 2015-04-08FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for pantoprazole sodium from Mylan Pharmaceuticals Inc. under ANDA.
-
FDA approval · 2015-04-08FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approves a supplemental application for pantoprazole from NorthStar RxLLC, indicating approval of a generic pantoprazole product.
-
FDA approval · 2015-04-08FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Pantoprazole Sodium from NorthStar Rx LLC under an ANDA (202038), authorizing regulatory action …
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Economic Impact of Guidelines for Gastroesophageal Reflux Disease [NA]
Completed clinical trial evaluating the economic impact of guidelines for gastroesophageal reflux disease, sponsored by the US Department of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-04-03FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic rabeprazole sodium (ANDA 090678), authorizing its marketing as a proton pump i…
-
FDA approval · 2015-04-02FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for rabeprazole sodium from Torrent Pharmaceuticals Limited under ANDA 202376, indicating a post…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: MSG and Gastrointestinal Motility [NA]
Clinical trial update indicating completion of a study evaluating monosodium glutamate and gastrointestinal motility in gastroesophageal ref…
-
FDA approval · 2015-03-20FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for omeprazole from Apotex Corp., authorizing a generic version of the drug.
-
CLINICAL_TRIALS research · 2015-03-20Clinical Trial Update: Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis [NA]
This clinical trial update reports on laryngeal and esophageal EGF receptor expression in patients with reflux laryngitis, related to gastro…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Influence of IPV on GOR in Infants From 0 to 12 Months. [NA]
A completed clinical trial assessed the influence of the Inactivated Poliovirus Vaccine (IPV) on gastroesophageal reflux in infants aged 0-1…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Safety Study of Airway Clearance Techniques in Infants. [NA]
A completed safety study evaluating airway clearance techniques in infants with gastroesophageal reflux; results were posted in 2015.
-
FDA approval · 2015-03-16FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for omeprazole submitted by Dr. Reddy's Laboratories Limited.
-
FDA label_change · 2015-03-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole submitted by Mylan Pharmaceuticals, indicating a change to the product labeling/aut…
-
FDA approval · 2015-03-06FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by AmerisourceBergen, under NDA 022032.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets [Phase 1]
Phase 1 sensory evaluation study of dexlansoprazole delayed-release orally disintegrating tablets completed, with results posted in 2015 reg…
-
FDA approval · 2015-03-02FDA Approved: OMEPRAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for omeprazole from Zydus Lifesciences Limited under the ANDA.
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US [Phase 4]
Phase IV GERD sleep study completed with results posted in 2015.
-
FDA approval · 2015-02-25FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA has approved a supplemental application for Pantoprazole Sodium from Torrent Pharmaceuticals Limited, resulting in the approval of the g…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Epithelial Damage in GERD
A completed clinical trial from Maastricht University Medical Center investigates epithelial damage in gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only
This entry summarizes a completed clinical trial focusing on reflux disease therapy in the management of childhood asthma, limited to data e…
-
CLINICAL_TRIALS research · 2015-01-29Clinical Trial Update: Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms [NA]
This document provides a clinical-trial update on the GERD-X system, evaluating full-thickness gastroplication for atypical gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of the Escherichia coli M17 probiotic for gastroesophageal reflux disease has comp…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Impact of Swaddle Blanket on Gastroesophageal Reflux [NA]
This clinical trial update describes a study assessing whether swaddling affects gastroesophageal reflux and related events (apnea, bradycar…
-
FDA approval · 2015-01-02FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for pantoprazole sodium filed by NorthStar Rx LLC.